ÂÜÀòÂÒÂ×

Arseniy Shabashvili is a Senior Associate in Equity Research at Guggenheim Partners, with extensive experience in the biopharma sector and financial analysis. Previously, Arseniy served as an Equity Research Associate at Mizuho, focusing on Vamil Divan's team, and completed an MBA internship at Deep Track Capital, where research on biotech equities was conducted for a hedge fund. Prior roles include Investment Manager at RBV Capital LP, where venture capital deals in life sciences were evaluated, and positions at Novartis, which included both strategy and scientific roles leading to significant acquisitions. Early career experience includes positions as an Associate Scientist and a Lab Technician at Banyan Biomarkers Inc and the University of Florida, where Arseniy contributed to peer-reviewed research. Arseniy holds an MBA from the University of Florida’s Warrington College of Business and a Bachelor of Science in Chemistry from the University of Florida.